Therapeutic efficacy of TriCell CD34+ cell-containing, platelet-rich plasma in alopecia patients
±è°æºÀ, ±è´ë°ü,
¼Ò¼Ó »ó¼¼Á¤º¸
±è°æºÀ ( Kim Kyung-Bong )
LOHAS Clinic
±è´ë°ü ( Kim Dae-Kwan )
REV-MED Inc. Stem Cell Research Institute
Abstract
Platelet-rich plasma (PRP) containing various growth factors and stem cells can play a role in tissue regeneration. Recently, treatments such as CD34+ cell-containing PRP has been used in various fields, including that of hair loss. The aim of this study was to evaluate the efficacy of CD34+ cell-containing PRP injections for the treatment of alopecia. We extracted PRP from the blood of 10 patients using the TriCell Platelet Concentrate System (REV-MED Technologies Corp.). TriCell CD34+ cell-containing PRP preparations were injected onto the scalps of 5 patients with androgenetic alopecia including 2 female patients with pattern hair loss and 3 patients with alopecia areata. There were no special side effects, and overall, hair thickness and density were improved. Three months of TriCell CD34+ cell-containing PRP therapy (at 4-week intervals) resulted in improved hair thickness and density in alopecia patients.
Å°¿öµå
alopecia; androgenetic alopecia; CD34+ cell; platelet-rich plasma therapy; TriCell platelet-rich plasma
¿ø¹® ¹× ¸µÅ©¾Æ¿ô Á¤º¸
µîÀçÀú³Î Á¤º¸